InsidersTradesSigma
Explore the complete record of transactions filed by Wolff Stefani, Chief Operating Officer. Insider active across 1 company, notably Nurix Therapeutics, Inc.. In total, 1 reports have been logged. Activity tracked since 30 April 2022. The latest transaction was filed on 30 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Wolff Stefani is the EVP and COO at Nurix Therapeutics, Inc. She oversees the company's operations, contributing to efficiency and implementation of the strategy.